Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole

Journal of Medical Microbiology

Volumn 47, Issue 4, 1998, Pages 359-363

  Natarajan, U ^a   Randhawa, N ^a   Brummer, E ^a,b   Stevens, D A ^a,b  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; EFFECTOR CELL; FUNGICIDAL ACTIVITY; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0031908660     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-47-4-359     Document Type: Article

References (14)

1. Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood 1986; 67: 257-267.
2. Gasson JC, Weisbart RH, Kaufman SE et al. Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. Science 1984; 226: 1339-1342.
3. Weisbart RH, Kwan L, Golde DW, Gasson JC. Human GM-CSF primes neutrophils tor enhanced oxidative metabolism in response to the major physiological chemoattractants. Blood 1987; 69: 18-21.
4. Wong GG, Witek JS, Temple PA et al. Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 1985; 228: 810-815.
5. Groopman JF, Mitsuyasu RT, DeLeo MH, Oette DH, Golde DW. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Eng J Med 1987; 317: 593-598.
6. Richardson MD, Brownlie CED, Shankland GS. Enhanced phagocytosis and intracellular killing of Candida albicans by GM-CSF activated human neutrophils. J Med Vet Mycol 1992; 30: 433-441.
7. Smith PD, Lamerson CL, Banks S et al. Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. J Infect Dis 1990; 161: 999-1005.
8. Nathan CE Respiratory burst in adherent human neutrophils: triggering by colony-stimulating factors CSF-GM and CSF-G. Blood 1989; 73: 301-306.
9. Brummer E, Stevens DA. Synergy of human neutrophils with fluconazole in killing Candida species. Mycopathologia 1996; 134: 115-120.
10. Garcha UK, Brummer E, Stevens DA. Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing Candida species. J Infect Dis 1995; 172: 1620-1623.
11. Maródi L, Forehand JR, Johnston RB. Mechanisms of host defense against Candida species II. Biochemical basis for the killing of Candida by mononuclear phagocytes. J Immunol 1991; 146: 2790-2794.
12. Bermudez LE, Young LS. Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex. J Leukoc Biol 1990; 48: 67-73.
13. Weiser WY, Van Niel A, Clark SC, David JR, Remold HG. Recombinant human granulocyte macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages. J Exp Med 1987; 166: 1436-1446.
14. Reed SG, Nathan CF, Pihl DL et al. Recombinant granulocyte macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon γ. J Exp Med 1987; 166: 1734-1746.